missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18146966

ROR beta Antibody (OTI1G1), DyLight 755, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-73930IR

Product Code. 18146966

  • € 807.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

ROR beta Monoclonal specifically detects ROR beta in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

ROR beta
Monoclonal
DyLight 755
50mM Sodium Borate with 0.05% Sodium Azide
RORB
Recombinant protein fragment corresponding to amino acids 1-260 of human ROR beta (NP_008845) produced in E.coli.
0.1 mL
Primary
Human, Mouse, Rat
IgG1
Western Blot, Immunohistochemistry
OTI1G1
Western Blot, Immunohistochemistry
NR1F2nuclear receptor ROR-beta, Nuclear receptor RZR-beta, Nuclear receptor subfamily 1 group F member 2, RAR-related orphan receptor B, RAR-related orphan receptor beta, retinoic acid-binding receptor beta, retinoid-related orphan receptor beta, Retinoid-related orphan receptor-beta, ROR-BETA, RZRBbA133M9.1, RZR-BETA
Mouse
Affinity Purified
GPCR
6096.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.